Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ENVB holding history

Enveric Biosciences, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENVB overviewAll 13F holders of ENVBFull Q2 2026 holdings

Shares (Q2 2026)
201
Value
$277
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ENVB by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026201$277<0.1%−3,411−94.4%ReducedHolders
Q1 20263,612$7.01K<0.1%+717+24.8%AddedHolders
Q4 20252,895$10.5K<0.1%−102,438−97.3%ReducedHolders
Q3 2025105,333$67.3K<0.1%+77,994+285.3%AddedHolders
Q2 202527,339$33.1K<0.1%−15,421−36.1%ReducedHolders
Q1 202542,760$59.4K<0.1%−35,648−45.5%ReducedHolders
Q4 202478,408$28.1K<0.1%+77,677+10,626.1%AddedHolders
Q3 2024731$346<0.1%−42,829−98.3%ReducedHolders
Q2 202443,560$27.3K<0.1%+38,577+774.2%AddedHolders
Q1 20244,983$4.98K<0.1%+4,973+49,730.0%AddedHolders
Q4 202310$13<0.1%−301−96.8%ReducedHolders
Q3 2023311$740<0.1%+257+475.9%AddedHolders
Q2 202354$182<0.1%−5,264−99.0%ReducedHolders
Q1 20235,318$8.85K<0.1%+2,912+121.0%AddedHolders
Q4 20222,406$5.00K<0.1%−2,796−53.7%ReducedHolders
Q3 20225,202$22.0K<0.1%+5,192+54,428.3%AddedConverted for a 1-for-50 splitHolders
Q2 2022477$00.0%−97,427−99.5%ReducedHolders
Q1 202297,904$32.0K<0.1%+83,938+601.0%AddedHolders
Q4 202113,966$13.0K<0.1%+13,489+2,827.9%AddedHolders
Q3 2021477$1.00K<0.1%−66,919−99.3%ReducedHolders
Q2 202167,396$160.0K<0.1%+35,924+114.1%AddedHolders
Q1 202131,472$97.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.